炎症反应驱动乳腺癌转移的研究进展  

The research progress of inflammatory reaction driving breast cancer metastasis

作　　者：刘冬 张太娟(综述) 党计锋(审校) LIU Dong;ZHANG Taijuan;DANG Jifeng(Department of Radiology,Qingdao Hiser Hospital Affiliated of Qingdao University(Qingdao Traditional Chinese Medicine Hospital),Qingdao 266033,China)

机构地区：[1]青岛大学附属青岛市海慈医院(青岛市中医医院)放射科,青岛266033

出　　处：《实用肿瘤学杂志》2024年第5期336-341,共6页Practical Oncology Journal

摘　　要：乳腺癌治疗面临的最大挑战是转移和耐药,乳腺癌转移增加患者死亡风险并降低生存质量。目前乳腺癌的转移机制尚未完全明确,转移的多步骤过程即转移级联,是由肿瘤细胞的内在特性和肿瘤微环境共同决定的。在驱动乳腺癌转移的因素中,炎症反应的作用逐渐受到重视。由免疫细胞、细胞因子、趋化因子和生长因子组成的炎症环境对癌细胞的侵袭和转移有重要影响。通过研究炎症反应与肿瘤细胞及肿瘤微环境之间的相互作用,有望发现预防和治疗乳腺癌转移的药物靶点。本文就炎症反应在乳腺癌转移肿瘤微环境中的作用进行综述。The biggest challenge of breast cancer treatment is metastasis and drug resistance.Breast cancer metastasis increases mortality and decreases the life quality of patients.At present,the mechanism of breast cancer metastasis is not completely understood,and the multi-step process of metastasis,namely metastasis cascade,is determined by the internal characteristics of tumor cells and tumor microenvironment.Among the factors driving breast cancer metastasis,the role of inflammatory reaction has gradually attracted attention.The inflammatory environment composed of immune cells,cytokines,chemokines,and growth factors has an important impact on the invasion and metastasis of cancer cells.By studying the interaction between inflammatory reaction,tumor cells and tumor microenvironment,it is expected to discover drug targets for the prevention and treatment of breast cancer metastasis.This article reviews the role of inflammation in the tumor microenvironment of breast cancer metastasis.

关 键 词：乳腺癌 炎症反应 转移 

分 类 号：R737.9[医药卫生—肿瘤]